Ticker,Title,Link
JSPR,Jasper Therapeutics (JSPR) Gets a Buy from Stifel Nicolaus,8/19/2024 2:15:13 AM
JSPR,Oppenheimer Sticks to Their Buy Rating for Jasper Therapeutics (JSPR),8/14/2024 11:46:33 AM
JSPR,JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024,8/13/2024 5:55:21 PM
JSPR,Briquilimab: A Promising New Treatment in Chronic Urticaria with Superior Efficacy and Safety Profile,8/5/2024 10:21:11 AM
JSPR,Jasper Therapeutics (JSPR) Gets a Buy from Evercore ISI,7/31/2024 1:38:05 PM
JSPR,Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Jasper Therapeutics (JSPR),7/23/2024 12:31:14 AM
JSPR,TD Cowen Remains a Buy on Jasper Therapeutics (JSPR),7/10/2024 11:16:25 AM
JSPR,Buy Rating for Jasper Therapeutics: Promising Pipeline and Market Disruption Potential with Briquilimab,7/8/2024 10:35:19 AM
JSPR,Briquilimab’s Market Edge and Untapped Value: A Buy Rating for Jasper Therapeutics,6/26/2024 8:35:16 PM
JSPR,"Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors",6/19/2024 2:00:00 PM
JSPR,Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit,6/17/2024 10:30:00 PM
JSPR,Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress,6/14/2024 2:00:11 PM
JSPR,Buy Rating Affirmed for Jasper Therapeutics Amid Promising Briquilimab Trials and Pipeline Expansion,6/11/2024 2:15:57 AM
JSPR,Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024,5/31/2024 12:05:18 AM
JSPR,Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference,5/29/2024 10:30:39 PM
JSPR,TD Cowen Sticks to Their Buy Rating for Jasper Therapeutics (JSPR),5/21/2024 11:37:32 AM
JSPR,Buy Rating for Jasper Therapeutics Amid Promising briquilimab Trials and Asthma Market Potential,5/20/2024 6:25:32 PM
JSPR,RBC Capital Sticks to Their Buy Rating for Jasper Therapeutics (JSPR),5/15/2024 10:32:15 AM
JSPR,JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024,5/14/2024 5:53:51 PM
JSPR,"Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)",5/13/2024 3:50:16 PM
JSPR,Jasper Therapeutics to Present at Upcoming Investor Conferences in May,5/7/2024 10:30:31 PM
JSPR,Briquilimab’s Market Potential and Competitive Advantage in Autoimmune Diseases: An Investment Opportunity,5/6/2024 10:18:45 AM
JSPR,"TipRanks ‘Perfect 10’ List: These 2 Top-Scoring Stocks Could Double (or More), According to Analysts",5/2/2024 1:50:43 PM
JSPR,Buy Rating Affirmed: Jasper Therapeutics’ Briquilimab Shows Promising Outlook in Chronic Urticaria Treatment Market,4/25/2024 2:55:23 AM
JSPR,Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference,4/2/2024 10:30:19 PM
JSPR,"RBC starts Jasper Therapeutics at outperform, cites market opportunity",3/28/2024 8:03:29 PM
JSPR,Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference,3/21/2024 9:30:22 PM
JSPR,Buy Rating Affirmed for Jasper Therapeutics as Briquilimab Shows Market Potential in Chronic Urticaria Treatment,3/20/2024 1:05:24 PM
JSPR,Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria,3/19/2024 1:00:25 PM
JSPR,Buy Rating for Jasper Therapeutics: Promising Prospects for Briquilimab in Treating Chronic Urticaria,3/18/2024 9:45:29 AM
JSPR,New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia,3/15/2024 1:00:00 PM
JSPR,"Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Biomea Fusion (BMEA) and Jasper Therapeutics (JSPR)",3/7/2024 12:41:09 PM
JSPR,JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023,3/6/2024 5:53:30 PM
JSPR,Buy Rating Affirmed: Jasper Therapeutics’ Progress and Potential in Addressing Unmet Needs in Chronic Urticaria Treatment,3/4/2024 6:15:22 PM
JSPR,Oppenheimer Reaffirms Their Buy Rating on Jasper Therapeutics (JSPR),2/27/2024 12:48:59 PM
JSPR,Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference,2/26/2024 10:30:57 PM
JSPR,"Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting",2/23/2024 2:00:38 PM
JSPR,Buy Rating for Jasper Therapeutics: Promising Developments in CSU Treatment Pipeline and Anticipated Clinical Milestones,2/21/2024 2:45:26 PM
JSPR,"Tenax Therapeutics, Equillium among healthcare movers",2/7/2024 3:00:01 PM
JSPR,Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,2/6/2024 7:17:47 PM
JSPR,"Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting",2/5/2024 2:00:04 PM
JSPR,"Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",2/2/2024 2:00:32 PM
